Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.
This article is from
The Cancer Letter
archive.
Vol. 27 No. 13 | March 30, 2001
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
NIDDK Funds Trial On treatment Of Chronic Hepatitis C
August 13, 1999
TCL Archive
NSABP Investigator Recounts Loyalty To Fisher, “Betrayal”
June 3, 1994
TCL Archive
Drug Bills Cut $500 Million From Cancer Care, ASCO Says.
July 4, 2003
TCL Archive
House Committee Seeks Information on ImClone Insider Stock Trading.
March 29, 2002
TCL Archive
House Passes Cancer Bill With Mandates for NCI
September 28, 2012
TCL Archive
Clinical Education Program Phase Out Opposed By NCAB Committee
February 14, 1986